Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

[1]  Warren Strober,et al.  Trypan Blue Exclusion Test of Cell Viability , 2001, Current protocols in immunology.

[2]  L LongoDan,et al.  Harrisons principles of internal medicine , 2013 .

[3]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[4]  John Connett,et al.  Azithromycin for prevention of exacerbations of COPD. , 2011, The New England journal of medicine.

[5]  J. Soriano,et al.  Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. , 2011, Proceedings of the American Thoracic Society.

[6]  C. Lloyd,et al.  Functions of T cells in asthma: more than just TH2 cells , 2010, Nature Reviews Immunology.

[7]  Laboratory Growth and Maintenance of Haemophilus influenzae , 2010, Current protocols in microbiology.

[8]  P. Paré,et al.  Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[9]  T. Goldmann,et al.  Open Access Research , 2022 .

[10]  J. Alcorn,et al.  TH17 cells in asthma and COPD. , 2010, Annual review of physiology.

[11]  Lior Pachter,et al.  Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.

[12]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[13]  A. Agustí,et al.  Nontypeable Haemophilus influenzae Clearance by Alveolar Macrophages Is Impaired by Exposure to Cigarette Smoke , 2009, Infection and Immunity.

[14]  W. Timens,et al.  Lymphoid follicles in (very) severe COPD: beneficial or harmful? , 2009, European Respiratory Journal.

[15]  M. Stämpfli,et al.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer , 2009, Nature Reviews Immunology.

[16]  M. Stämpfli,et al.  Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. , 2009, American journal of respiratory and critical care medicine.

[17]  S. Duncan,et al.  Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease , 2008, International journal of chronic obstructive pulmonary disease.

[18]  V. Kuchroo,et al.  Induction and effector functions of TH17 cells , 2008, Nature.

[19]  P. Hutchinson,et al.  Cytotoxic T lymphocyte and natural killer cell responses to non‐typeable Haemophilus influenzae , 2008, Clinical and experimental immunology.

[20]  S. Hodge,et al.  Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects , 2007, Clinical and experimental immunology.

[21]  H. Coxson,et al.  Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.

[22]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[23]  R. Homer,et al.  State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. , 2006, Proceedings of the American Thoracic Society.

[24]  John D. Mitchell,et al.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. , 2005, American journal of respiratory and critical care medicine.

[25]  A. Torres,et al.  Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.

[26]  M. Pouladi,et al.  Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. , 2004, American journal of respiratory and critical care medicine.

[27]  J. Hogg,et al.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.

[28]  J. Elias.  The relationship between asthma and COPD. Lessons from transgenic mice. , 2004, Chest.

[29]  T. Wynn.  Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[30]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[31]  J. Bartlett.  Persistent colonization by haemophilus influenzae in chronic obstructive pulmonary disease , 2004 .

[32]  T. Wynn.  Fibrotic disease and the T(H)1/T(H)2 paradigm. , 2004, Nature reviews. Immunology.

[33]  E. Wouters,et al.  Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. , 2003, Respiratory medicine.

[34]  E. Mason,et al.  Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non‐typeable Haemophilus influenzae , 2003, FEMS Immunology and Medical Microbiology.

[35]  P. Hutchinson,et al.  Adaptive immunity to nontypeable Haemophilus influenzae. , 2003, American journal of respiratory and critical care medicine.

[36]  T. Seemungal,et al.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.

[37]  E. Mason,et al.  Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. , 2001, American journal of respiratory and critical care medicine.

[38]  S. Shapiro,et al.  End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on. , 2001, American journal of respiratory and critical care medicine.

[39]  A. Forsgren,et al.  The importance of a β-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells , 2001 .

[40]  C. Janeway,et al.  T Cell-Mediated Immunity , 2001 .

[41]  A. Forsgren,et al.  The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. , 2001, The Journal of infectious diseases.

[42]  R. Stockley,et al.  Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.

[43]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[44]  W. Timens,et al.  Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[45]  A. Lindberg,et al.  Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay , 1994, Infection and immunity.